The role of pemetrexed in treating lung cancer

Abstract

Pemetrexed represents the first member of the novel class of antifolates - MTA. Clinical trials have clearly demonstrated its high efficacy in the treatment of NSCLC.

Keywords

• Pemetrexed
• NSCLC
• first-line treatment
• second-line treatment